Significance: Scramblases translocate lipids across the lipid bilayer without consumption of ATP, thereby regulating lipid distributions in cellular membranes. Cytosol-to-lumen translocation across the endoplasmic reticulum (ER) membrane is a common process among lipid glycoconjugates involved in posttranslational protein modifications in eukaryotes. These translocations are thought to be mediated by specific ER-resident scramblases, but the identity of these proteins and the underlying molecular mechanisms have been elusive. Here, we show that CLPTM1L, an integral membrane protein with eight putative transmembrane domains, is the major lipid scramblase involved in efficient glycosylphosphatidylinositol biosynthesis in the ER membrane. Our results validate the long-standing hypothesis that lipid scramblases ensure the efficient translocations of lipid glycoconjugates across the ER membrane for protein glycosylation pathways.
30 June 2021 in Journal of the American Chemical Society
Sequential mannose trimming of N-glycan, from M9 to M8B and then to oligosaccharides exposing the α1,6-linked mannosyl residue (M7A, M6, and M5), facilitates endoplasmic reticulum-associated degradation of misfolded glycoproteins (gpERAD). We previously showed that EDEM2 stably disulfide-bonded to the thioredoxin domain-containing protein TXNDC11 is responsible for the first step (George et al., 2020). Here, we show that EDEM3 and EDEM1 are responsible for the second step. Incubation of pyridylamine-labeled M8B with purified EDEM3 alone produced M7 (M7A and M7C), M6, and M5. EDEM1 showed a similar tendency, although much lower amounts of M6 and M5 were produced. Thus, EDEM3 is a major α1,2-mannosidase for the second step from M8B. Both EDEM3 and EDEM1 trimmed M8B from a glycoprotein efficiently. Our confirmation of the Golgi localization of MAN1B indicates that no other α1,2-mannosidase is required for gpERAD. Accordingly, we have established the entire route of oligosaccharide processing and the enzymes responsible.
Prion diseases are transmissible, lethal neurodegenerative disorders caused by accumulation of the aggregated scrapie form of prion protein (PrPSc) after conversion of cellular prion protein (PrPC). The glycosylphosphatidylinositol (GPI) anchor of PrPC is involved in prion disease pathogenesis, and especially sialic acid in a GPI side-chain reportedly affects the PrPC conversion. Thus, it is important to define the location and structure of the GPI anchor in human PrPC. Moreover, the sialic acid linkage–type in the GPI side-chain has not been determined for any GPI-anchored protein. Here, we report GPI-glycan structures of human PrPC isolated from human brain and from brains of a knock-in mouse model in which the mouse prion protein (Prnp) gene was replaced with the human PRNP gene. Liquid chromatography–electrospray ionization MS (LC–ESI–MS) analysis of human PrPC from both biological sources indicated that Gly-229 is the ω site in PrPC to which GPI is attached. Gly-229 in human PrPC does not correspond to Ser-231, the previously reported ω site of Syrian hamster PrPC. We found that approximately 41% and 28% of GPI anchors in human PrPCs from human and mouse knock-in brains, respectively, have N-acetylneuraminic acid in the side-chain. Using a sialic acid linkage–specific alkylamidation (SALSA) method to discriminate α2,3-linkage from α2,6-linkage, we found that N-acetylneuraminic acid in PrPC’s GPI side-chain is linked to galactose through an α2,3-linkage. In summary, we report the GPI-glycan structure of human PrPC, including the ω-site amino acid for GPI attachment and the sialic acid linkage type.